Search
Home
|
Contact Us
|
Mailing list
|
PORTAL ACCESS
About
Pipeline
Technology
Partnering
News
Careers
Investors
Clinical_Trials
Home
>
News
News
ANTI-ANXIETY COMPOUND BNC210 PHASE I TRIAL SUCCESSFUL: ESTABLISHES FOUR-FOLD INCREASE IN BLOOD DRUG LEVELS FOLLOWING FOOD INTAKE
21-Jun-2010
Download
69 kb
Top